Insight

Anand Patel: Analysis of intensive chemotherapy in CBF-AML

Photo from

Jul 26, 2024, 00:17

Anand Patel: Analysis of intensive chemotherapy in CBF-AML

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a post on X:

“Our analysis of intensive chemotherapy (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek.

We found:
-similar EFS/OS between IC + GO and IC alone
-longer 3y EFS with IC + KIT inhibitor (85%)

We eagerly await NCT02013648 results!

A huge thanks to co-authors Yasmin Abaza, Charlie Foucar, Rory M. Shallis, Talha Badar and those not on twitter!“

Real-world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia

Autors: Alexandra E. Rojek, Benjamin J. McCormick, Joanna Cwykiel, Oluwatobi Odetola, Yasmin Abaza, Nhi Nai, Charles E. Foucar, Rohan K. Achar, Rory M. Shallis, Danielle Bradshaw, Meaghan Standridge, Vamsi Kota, Guru Subramanian Guru Murthy, Talha Badar, Anand A. Patel.

Anand Patel

Source: Anand Patel/X

Alexandra E. Rojek Anand A. Patel Anand Patel Benjamin J. McCormick cancer Charles E. Foucar Danielle Bradshaw eJHaem journal Guru Subramanian Guru Murthy Joanna Cwykiel Meaghan Standridge Nhi Nai Oluwatobi Odetola OncoDaily Oncology Rohan K. Achar Rory M. Shallis Talha Badar Vamsi Kota Yasmin Abaza

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage